2 active not recruiting, 1 completed, 1 not yet recruiting, 1 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Active not recruiting 2, Completed 1, Not yet recruiting 1, Terminated 1 |
Follow SGLT2i: new trials by email Literature Review of SGLT2i trials Research Report on SGLT2i
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease Dulaglutide, SGLT2i, Finerenone - T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wannan Medical College | 468 | 2026-05-01 | 2026-04-22 |
| Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension JARDIANCE 25mg, Placebo - Kidney Transplantation Recipients, Magnetic Resonance Imaging (MRI) | Phase 4 | Active not recruiting | Odense University Hospital | 8 | 2025-03-27 | 2025-07-31 |
| proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2 Dapagliflozin 10 MG Oral Tablet [Farxiga], Placebo - Acute Kidney Injury, Cardiac Surgery | Phase 4 | Active not recruiting | Amsterdam UMC | 784 | 2023-06-09 | 2025-05-18 |
| The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure SGLT2i, No SGLT2i - Acute Decompensated Heart Failure | Phase 4 | Terminated | University of Chicago | 1 | 2023-05-22 | 2024-09-04 |
| HF Patients With LVADs Being Treated With SGLT2i SGLT2i, No SGLT2i - Heart Failure With Reduced Ejection Fraction | Phase 4 | Completed | University of Chicago | 32 | 2022-09-08 | 2026-06-03 |
Acute Kidney Injury (1) · Diabetes Mellitus, Type 2 (1) · Renal Insufficiency, Chronic (1)
University of Chicago (2) · Amsterdam UMC (1) · First Affiliated Hospital of Wannan Medical College (1) · Odense University Hospital (1)
United States (2) · Denmark (1) · Netherlands (1)
Jonathan Grinstein, MD (1) · Lotte B Lange, MD (1) · Mark Belkin, MD (1)